Alonso Zugarazo

Alonso Zugarazo is an experienced executive in the pharmaceutical industry, currently serving as General Manager for Latin America North at Biogen since June 2025. Previously, Zugarazo was the General Manager for Recordati Rare Diseases in Mexico, where notable accomplishments included a full P&L turnaround leading to 250% growth over three years. Earlier roles include General Manager for Knight Therapeutics in Latin America, where Zugarazo oversaw operations across multiple countries, and Business Unit Director at Takeda, managing a significant P&L in rare diseases and immunology. Zugarazo also held key positions at Sanofi, GSK, and GE Capital, showcasing a solid track record in strategic management, commercial development, and driving substantial sales growth across various therapeutic areas. Zugarazo holds an MBA from IPADE Business School and a B.B.A. from the University of St. Thomas.